<?xml version="1.0" encoding="UTF-8" standalone="yes"?><response><header><requestMsgID></requestMsgID><responseTime>2025-11-17 18:38:28.3828</responseTime><responseMsgID></responseMsgID><successYN>Y</successYN><resultCode>00</resultCode><resultMsg>NORMAL SERVICE.</resultMsg></header><body><item><biblioSummaryInfoArray><biblioSummaryInfo><applicationDate>2014.03.14</applicationDate><applicationFlag>특허</applicationFlag><applicationNumber>10-2024-7040171</applicationNumber><claimCount>1</claimCount><examinerName> </examinerName><finalDisposal> </finalDisposal><inventionTitle>T 조절 세포의 증식을 위한 인터류킨-2 뮤테인</inventionTitle><inventionTitleEng>INTERLEUKIN-2 MUTEINS FOR THE EXPANSION OF T-REGULATORY CELLS</inventionTitleEng><openDate>2025.01.07</openDate><openNumber>10-2025-0002742</openNumber><originalApplicationDate>2014.03.14</originalApplicationDate><originalApplicationKind>국제출원/분할</originalApplicationKind><originalApplicationNumber>10-2023-7037995</originalApplicationNumber><originalExaminationRequestDate>2024.12.31</originalExaminationRequestDate><originalExaminationRequestFlag>Y</originalExaminationRequestFlag><publicationDate> </publicationDate><publicationNumber> </publicationNumber><registerDate> </registerDate><registerNumber> </registerNumber><registerStatus>공개</registerStatus><translationSubmitDate>2024.12.03</translationSubmitDate></biblioSummaryInfo></biblioSummaryInfoArray><ipcInfoArray><ipcInfo><ipcDate>(2006.01.01)</ipcDate><ipcNumber>C07K 14/55</ipcNumber></ipcInfo><ipcInfo><ipcDate>(2006.01.01)</ipcDate><ipcNumber>A61K 38/20</ipcNumber></ipcInfo></ipcInfoArray><familyInfoArray><familyInfo><familyApplicationNumber>1020237037995</familyApplicationNumber></familyInfo></familyInfoArray><abstractInfoArray><abstractInfo><astrtCont> T 조절 세포를 우선적으로 증식시키고 활성화하고 대규모 제조에 수정 가능한, IL-2 뮤테인 및 IL-2 뮤테인 Fc-융합 분자가 본 명세서에 제공된다. N297에서의 글라이코실화 결여에도 불구하고 고도로 감소한 이팩터 기능 및 높은 안정성이 결여되거나 갖는, 변이체 인간 IgG1 Fc 분자가 또한 본 명세서에 제공된다. 또한, 포유동물 세포에서 발현될 때 글라이코실화된 링커 펩타이드가 본 명세서에 제공된다. </astrtCont></abstractInfo></abstractInfoArray><internationalInfoArray><internationalInfo><internationOpenDate>2014.09.25</internationOpenDate><internationOpenNumber>WO2014153111</internationOpenNumber><internationalApplicationDate>2014.03.14</internationalApplicationDate><internationalApplicationNumber>PCT/US2014/029111</internationalApplicationNumber></internationalInfo></internationalInfoArray><claimInfoArray><claimInfo><claim>1. i) 아미노산 서열의 125번 위치가 알라닌이거나, ii) 아미노산 서열의 125번 위치가 알라닌이고, 아미노산 서열이 V69A 및 Q74P 치환을 포함하는, 서열 번호 1에 기재된 아미노산 서열을 포함하고, T 조절 세포를 우선적으로 자극하는 인간 인터류킨-2 (IL-2) 뮤테인의 용도.</claim></claimInfo></claimInfoArray><applicantInfoArray><applicantInfo><address>미국 캘리포니아 *****-****, 사우전드 오크, 원 암젠  센터 드라이브</address><code>520060171104</code><country>미국</country><engName>AMGEN Inc.</engName><name>암젠 인크</name></applicantInfo></applicantInfoArray><inventorInfoArray><inventorInfo><address>미국 ***** 워싱턴주 배...</address><code> </code><country>미국</country><engName>GAVIN, Marc A.</engName><name>가빈, 마크 에이.</name></inventorInfo><inventorInfo><address>미국 ***** 캘리포니아...</address><code> </code><country>미국</country><engName>KANNAN, Gunasekaran</engName><name>칸난, 구나세카란</name></inventorInfo><inventorInfo><address>미국 ***** 워싱턴주 사마미...</address><code> </code><country>중국</country><engName>LI, Li</engName><name>리, 리</name></inventorInfo><inventorInfo><address>미국 ***** 워싱턴주...</address><code> </code><country>미국</country><engName>PEARSON, Joshua T.</engName><name>피어슨, 조슈아 티.</name></inventorInfo><inventorInfo><address>미국 ***** 캘리포니아주...</address><code> </code><country>미국</country><engName>KAROW, Margaret</engName><name>카로우, 마가레트</name></inventorInfo></inventorInfoArray><agentInfoArray><agentInfo><address>서울 중구 정동길 **-** (정동, 정동빌딩) **층(김.장법률사무소)</address><code>919980003836</code><country>대한민국</country><engName>LEE, Kuiy Dong</engName><name>이귀동</name></agentInfo><agentInfo><address>서울특별시 종로구 사직로*길 **, 세양빌딩 (내자동) *층(김.장법률사무소)</address><code>919980003619</code><country>대한민국</country><engName>YANG, Young June</engName><name>양영준</name></agentInfo></agentInfoArray><priorityInfoArray><priorityInfo><priorityApplicationCountry>미국</priorityApplicationCountry><priorityApplicationDate>2013.03.14</priorityApplicationDate><priorityApplicationNumber>61/784,669</priorityApplicationNumber></priorityInfo></priorityInfoArray><designatedStateInfoArray/><priorArtDocumentsInfoArray/><legalStatusInfoArray><legalStatusInfo><commonCodeName>수리 (Accepted) </commonCodeName><documentEngName>[Divisional Application(International Application)] Patent Application</documentEngName><documentName>[분할출원(국제출원)]특허출원서</documentName><receiptDate>2024.12.03</receiptDate><receiptNumber>1-1-2024-1337772-88</receiptNumber></legalStatusInfo><legalStatusInfo><commonCodeName>수리 (Accepted) </commonCodeName><documentEngName> </documentEngName><documentName>[심사청구]심사청구서·우선심사신청서</documentName><receiptDate>2024.12.31</receiptDate><receiptNumber>1-1-2024-1462738-34</receiptNumber></legalStatusInfo></legalStatusInfoArray><imagePathInfo><docName>1020247040171.jpg</docName><largePath>http://plus.kipris.or.kr/kiprisplusws/fileToss.jsp?arg=6c650beb4cee9ce4122b704b88878c93b2b4840edc8011603429fef83441bd77c2b1da9d35f7e5cd2d2663ab0681e37c95c31a7438ddf594f2a2fa89ef4a8785c0703670e4ef7db8</largePath><path>http://plus.kipris.or.kr/kiprisplusws/fileToss.jsp?arg=ed43a0609e94d6e22d01c5c32ba711cf29af1ed9ae3e78d6d1824514ebc1f82c84d8b1000a63ffe5a09d576e4bf93f5415dd4e33d3299e02c0392cb4e9c36fa8b07d803599c2f449</path></imagePathInfo><rndInfoArray/></item></body><count><numOfRows>1</numOfRows><pageNo>1</pageNo><totalCount>1</totalCount></count></response>